MRC Molecular Haematology Unit
At the MRC Molecular Haematology Unit, we aim to understand how stem cells produce mature blood cells in a healthy context, and how this process is perturbed in common blood disorders.
MRC MHU includes 14 research teams with over 140 scientists who share a common goal, to improve the prognosis of patients with inherited and acquired blood diseases.
This is an exciting time for the field of haematology. The -omics revolution is enabling scientists to unravel the complex molecular processes governing biology at unprecedented speed. At the MRC MHU our teams are committed to applying such cutting-edge techniques to better understand the molecular basis of blood diseases, and to develop treatments to improve the lives of patients. - Professor KJ Patel
Latest publications
TiO2 Alternative Coatings for Ferric Pyrophosphate Premixes: Stability and Bioaccessibility Relative to Ferrous Fumarate
Journal article
Teichman DL. et al, (2026), Innovative Food Science and Emerging Technologies, 111
Basophils drive the resolution and promote wound healing in adult and aged mice.
Journal article
Bex J. et al, (2026), J Exp Med, 223
Protecting lactoferrin for iron delivery: Effects of matrix composition and iron loading on gastric stability
Journal article
Blanco-Doval A. et al, (2026), Food Hydrocolloids, 174
Hypoxia inducible factors regulate pneumovirus replication by enhancing innate immune sensing.
Journal article
Ha J. et al, (2026), Proc Natl Acad Sci U S A, 123
Rethinking ovarian cancer III: the past decade and future directions
Journal article
Balkwill FR. et al, (2026), Nature Reviews Cancer